Taking on melanoma, one cell at a time
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
Broad/MIT scientist among five honored as pioneers of CRISPR-Cas9 system.
Genome-editing pioneer Feng Zhang hopes his work will shed light on neurological disorders.
Professor and director of the Broad Institute honored by the American Association for the Advancement of Science for outstanding contributions to science and society.
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Belcher, Bhatia, Brown, and Horvitz recognized for demonstrating a prolific spirit of innovation and invention resulting in a tangible impact on society.
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
With a new DARPA contract, biological engineer Christopher Voigt aims to harness the power of living cells.
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.
Three neuroscientists at MIT have been selected to receive awards from the Society for Neuroscience.